利用自动电子健康记录评分估算前列腺癌患者预期寿命
在退伍军人健康管理局(VHA)2013-2015年诊断的前列腺癌男性中,自动计算的Care Assessment Needs(CAN)评分与总生存独立相关,每5单位变化调整HR=1.17(95%CI 1.16-1.18),5年生存区分度优于两种合并症指数。
要点
- CAN评分自动计算,与前列腺癌诊断后中期生存独立相关。
- CAN评分5年生存AUC=0.76,优于PCCI(0.65)和Charlson指数(0.66)。
- CAN评分均值随分期升高:局限期46.5、局部晚期58.0、转移期68.1。
核心结论
- CAN评分与前列腺癌诊断后的中期生存强相关,可提供全自动的预期寿命估计以支持以患者为中心的癌症照护。
研究设计与样本
- 回顾性队列研究,纳入VHA 2013-2015年诊断的前列腺癌男性36,591例,其中35,364例(96.6%)有诊断前30天内自动计算的CAN评分(范围0-99)。
主要发现
- CAN评分与总体分期相关,局限期、局部晚期和转移期的平均评分分别为46.5(±22.4)、58.0(±24.4)和68.1(±24.3)。
- 未调整模型中CAN评分每5单位变化与生存相关HR=1.23(95%CI 1.22-1.24),调整前列腺癌风险后HR=1.17(95%CI 1.16-1.18)。
- CAN评分5年生存总体C-Index为0.74,AUC=0.76,优于PCCI(AUC=0.65)和Charlson合并症指数(AUC=0.66)。
临床怎么用
- CAN评分可作为自动化的预期寿命评估工具,辅助前列腺癌患者的个体化治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine if an automatically calculated electronic health record score can estimate intermediate-term life expectancy in men with prostate cancer to provide guideline concordant care. METHODS: We identified all men (n = 36,591) diagnosed with prostate cancer in 2013-2015 in the VHA. Of the 36,591, 35,364 (96.6%) had an available Care Assessment Needs (CAN) score (range: 0-99) automatically calculated in the 30 days prior to the date of diagnosis. It was designed to estimate short-term risks of hospitalization and mortality. We fit unadjusted and multivariable Cox proportional hazards regression models to determine the association between the CAN score and overall survival among men with prostate cancer. We compared CAN score performance to two established comorbidity measures: The Charlson Comorbidity Index and Prostate Cancer Comorbidity Index (PCCI). RESULTS: Among 35,364 men, the CAN score correlated with overall stage, with mean scores of 46.5 ( ± 22.4), 58.0 ( ± 24.4), and 68.1 ( ± 24.3) in localized, locally advanced, and metastatic disease, respectively. In both unadjusted and adjusted models for prostate cancer risk, the CAN score was independently associated with survival (HR = 1.23 95%CI 1.22-1.24 & adjusted HR = 1.17 95%CI 1.16-1.18 per 5-unit change, respectively). The CAN score (overall C-Index 0.74) yielded better discrimination (AUC = 0.76) than PCCI (AUC = 0.65) or Charlson Comorbidity Index (AUC = 0.66) for 5-year survival. CONCLUSION: The CAN score is strongly associated with intermediate-term survival following a prostate cancer diagnosis. The CAN score is an example of how learning health care systems can implement multi-dimensional tools to provide fully automated life expectancy estimates to facilitate patient-centered cancer care.
引用
- Soerensen SJC, Thomas IC, Schmidt B, et al. Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021. PMID: 34139251. doi:10.1016/j.urology.2021.05.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。